Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)

Youhong Dong1, Anping Wang1

  • 1Oncology Department, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China.

Oncology Letters
|August 15, 2014
PubMed

Insights

Aberrant DNA methylation silences tumor suppressor genes, increasing hepatocellular carcinoma (HCC) risk. DNA methylation patterns may predict HCC development, staging, and patient outcomes.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Aberrant DNA methylation is a key mechanism in cancer development, particularly in hepatocellular carcinoma (HCC).
  • Silencing of tumor suppressor genes via promoter CpG island hypermethylation is prevalent in HCC.
  • Environmental factors influence DNA methylation patterns, contributing to geographic variations in HCC incidence.

Purpose of the Study:

  • To investigate the role of DNA methylation in hepatocellular carcinoma (HCC) pathogenesis.
  • To explore the association between CpG island hypermethylation and HCC risk, especially in hepatitis B virus-related cases.
  • To determine the potential of DNA methylation as a biomarker for HCC prognosis.

Main Methods:

  • Analysis of DNA methylation status in HCC tissues and relevant gene promoters (e.g., p16 INK4a, p15 INK4b).
  • Investigation of the role of DNA methyltransferases (DNMTs) and microRNAs in hepatitis-related HCC.
  • Correlation of methylation profiles with clinical parameters including tumor stage and patient survival.

Main Results:

  • Promoter hypermethylation of tumor suppressor genes like p16 (INK4a) and p15 (INK4b) is linked to increased HCC risk.
  • Aberrant DNA methyltransferases (DNMTs) and microRNA dysregulation, influenced by hepatitis B virus X, contribute to hepatocarcinogenesis.
  • DNA methylation alterations correlate with HCC development, staging, survival, and recurrence.

Conclusions:

  • DNA methylation is a critical factor in HCC development and progression.
  • Specific DNA methylation markers hold potential for predicting HCC risk and patient outcomes.
  • Targeting DNA methylation pathways may offer therapeutic strategies for HCC.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...